This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mechanistic insight of the potential of geraniol against Alzheimer’s disease
European Journal of Medical Research Open Access 14 June 2022
-
Plasmonic nanoparticle amyloid corona for screening Aβ oligomeric aggregate-degrading drugs
Nature Communications Open Access 27 January 2021
-
Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer’s disease
Scientific Reports Open Access 20 February 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mount, C. & Downton, C. Alzheimer's disease: progress or profit? Nature Med. 12, 780–784 (2006).
Klafki, H. -W. et al. Therapeutic approaches to Alzheimer's disease. Brain 129, 2840–2855 (2006).
Masters, C. L. & Beyreuther, K. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Aβ amyloid pathway. Brain 129, 2823–2839 (2006).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Melnikova, I. Therapies for Alzheimer's disease. Nat Rev Drug Discov 6, 341–342 (2007). https://doi.org/10.1038/nrd2314
Issue Date:
DOI: https://doi.org/10.1038/nrd2314
This article is cited by
-
Investigation into Anti-Alzheimer Activity of Newly Developed Phthalimide Derivatives in Experimental Animals
Pharmaceutical Chemistry Journal (2023)
-
Mechanistic insight of the potential of geraniol against Alzheimer’s disease
European Journal of Medical Research (2022)
-
Plasmonic nanoparticle amyloid corona for screening Aβ oligomeric aggregate-degrading drugs
Nature Communications (2021)
-
Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer’s disease
Scientific Reports (2020)
-
Phytochemical profiling and in vitro screening for anticholinesterase, antioxidant, antiglucosidase and neuroprotective effect of three traditional medicinal plants for Alzheimer’s Disease and Diabetes Mellitus dual therapy
BMC Complementary and Alternative Medicine (2018)